1′-Acetoxychavicol Acetate Isolated from Alpinia galanga Ameliorates Ovalbumin-Induced Asthma in Mice

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Seo, Joung Wook ^a,b   Cho, Soon Chang ^c   Park, Sang Joon ^d   Lee, Eun Ji ^b   Lee, Jong Hwa ^a   Han, Sang Seop ^e   Pyo, Byeong Sik ^f   Park, Dae Hun ^f   Kim, Bong Hee ^b  

^a Korea Institute of Toxicology   (South Korea)

^b Chungnam National University   (South Korea)

^c Youngdong University   (South Korea)

^d Kyungpook National University   (South Korea)

^e Konyang University   (South Korea)

^f Dongshin University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

1' ACETOXYCHAVICOL; ANTIASTHMATIC AGENT; CD4 ANTIGEN; CD79 ANTIGEN; CD8 ANTIGEN; DEXAMETHASONE; GAMMA INTERFERON; GLYCOPROTEIN; IMMUNOGLOBULIN E; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; OVALBUMIN; UNCLASSIFIED DRUG; 1'-ACETOXYCHAVICOL ACETATE; BENZYL ALCOHOL DERIVATIVE; CYTOKINE; 1' ACETOXYCHAVICOL ACETATE;

AIRWAY REMODELING; ALLERGIC ASTHMA; ALPINIA; ALPINIA GALANGA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; ASTHMA; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL HYPERPLASIA; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DOWN REGULATION; DRUG STRUCTURE; EOSINOPHIL; FEMALE; GOBLET CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LUNG LAVAGE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHIZOME; T LYMPHOCYTE; TH1 CELL; TH2 CELL; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; CHEMISTRY; DISEASE MODEL; METABOLISM; CHEMICALLY INDUCED DISORDER;

ALPINIA; ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; BENZYL ALCOHOLS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; EOSINOPHILS; MICE; MICE, INBRED BALB C; OVALBUMIN;

EID: 84874544564     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056447     Document Type: Article

References (32)

1. World Health Organization (May 2011) Asthma; Fact sheet N°307.
2. Kay AB, (2001) Allergy and allergic diseases. First of two parts. N Engl J Med 344: 30-37.
3. National asthma education and prevention program (2002) Expert panel report: Guidelines for the diagnosis and management of asthma update on selected topics - 2002. J Allergy Clin Immunol 110(5 Suppl): S141-219.
4. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL, (1986) Two types of murine helper T cell clones 1. Definition according to profiles of lymphokines activieties and secreted protein. J Immunol 136: 2348-2367.
5. Mosmann TR, Coffiman RL, (1989) Th1 and Th2 cells: differenct patterens of lymphokine secrtion lead to different functional properties. Annu Rev Immunol 7: 145-168.
6. Rincon M, Irvin CG, (2012) Role of IL-6 in asthma and other inflammatory pulmonary diseases. Int J Biol Sci 8: 1281-1290.
7. Miteva L, Stanilova S, (2008) The combined effect of interleukin (IL)-10 and IL-12 polymorphisms on induced cytokine production. Hum Immunol 69: 562-566.
8. Commins SP, boorish L, Steinke JW, (2010) Immunologic messenger molecules: cytokines, interferons, and chemokines. J Allergy Clin Immunol 125: S53-S72.
9. Mamessier E, Magnan A, (2006) Cytokines in atopic disease revisiting the Th2 dogma. 16(2): 103-113.
10. Brightling CE, Symon FA, Birring SS, Bradding P, Pavord ID, et al. (2002) Th2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis. 110(6): 899-905.
11. Hershey GK, (2003) IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol 111: 677-690.
12. Rankin JA, Picarella DE, Geba GP, Temann UA, Prasad B, et al. (1996) Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc Natl Acad Sci USA 93: 7821-7825.
13. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, et al. (1998) Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261.
14. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, et al. (1999) Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, sub-epithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103: 779-788.
15. Mattes J, Yang M, Mahalingam S, Kuehr J, Webb DC, et al. (2002) Intrinsic defect in T cell production of Interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. 195(11): 1433-1444.
16. Bosnjak B, Stelzmuller B, Erb KJ, Epstein MM, (2011) Treatment of allergic asthma: modulation of Th2 cells and their responses. Respir Research 12: 114.
17. Barnes PJ, (1998) Current issues for establishing inhaled corticosteroids as the anti-inflammatory agents of choice in asthma. J Allergy Clin Immunol 101: S427-S433.
18. Kam JC, Szefler SJ, Surs W, Sher ER, Leung DY, (1993) Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol 151: 3460-3466.
19. Warrier PK, Nambiar VPK, Ramankutty C (1993 - 1995) Indian Medicinal Plants. Orient Longman Ltd., Madras Vol. 1-5.
20. Zheng GQ, Kenney PM, Lam LKT, (1993) Potential anticarcinogenic natural products isolated from lemongrass oil and galanga root oil. J Agric Food Chem. 41(2): 153-156.
21. Murakami A, Shigemori T, Ohigash H (2005) J Nutr Zingiberaceous and citrus constituents, 1′-Acetoxychavicol Acetate, Zerumbone, Auraptene, and Nobiletin, suppress lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 murine macrophages through different modes of action. 135(12 Suppl): 2987S-2982S.
22. Ando S, Matsuda H, Morikawa T, Yoshikawa M, (2005) 1′S'-1′-Acetoxychavicol acetate as a new type inhibitor of interferon-? production in lipopolysaccharide-activated mouse peritoneal macrophages. Bioorg Med Chem 13: 3289-3294.
23. Matsuda H, Morikawa T, Managi H, Yoshikawa M, (2003) Antiallergic principles from Alpinia galanga: structural requirements of phenylpropanoids for inhibition of degranulation and release of TNF-a and IL-4 in RBL-2H3 cells. Bioorg Med Chem Letters 13: 3197-3202.
24. Min HJ, Nam JW, Yu ES, Hong JH, Seo EK, et al. (2009) Effect of naturally occurring hydroxychavicol acetate on the cytokine production in T helper cells. Int Immunopharmacol 9: 448-454.
25. Ferreira MAR, (2004) Inflammation in allergic asthma: initiating events, immunological response and risk factors. Respirology 9: 16-24.
26. Rothenberg ME, (1998) Eosinophilia N Engl J Med. 338: 1592-1600.
27. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, et al. (1992) Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 326: 298-304.
28. Ding J, Yang S, Xu R, (1989) The inhibitory effect of hydrocortisone on interferon production by rat spleen cells. J Steroid Biochem 33(6): 1139-1141.
29. Corrigan CJ, Kay AB, (1991) CD4 T lymphocyte activation in acute severe asthma. Int Arch Allergy Appl Immunol 94: 270-271.
30. Cembrzynska-Nowak M, Szklarz E, Inglot AD, Teodorczyk-Injeyan JA, (1993) Elevated release of tumor necrosis factor-alpha and interferon-gamma by bronchoalveolar leukocytes from patients with bronchial asthma. Am Rev Respir Dis 147: 291-295.
31. Magnan AO, Mely LG, Camilla CA, Badier MM, Montero-Julian FA, et al. (2000) Assessment of the Th1/Th2 paradigm in whole blood in atopy and asthma. Increased IFN-gamma-producing CD8(+) T cells in asthma. Am J Respir Crit Care Med 161: 1790-1796.
32. Carson FL, Hladik C (2009). Histotechnology: A Self-Instructional Text (3 ed.). Hong Kong: American Society for Clinical Pathology Press. 137-139.